End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
153.9 INR | -1.31% | -2.90% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 1,462 | 1,719 | 2,118 | 2,428 | 3,374 | 3,610 |
EBITDA 1 | 255.8 | 362.4 | 351.7 | 491.3 | 724.1 | 715.6 |
EBIT 1 | 174.8 | 279.8 | 249.3 | 374.6 | 604.5 | 594.4 |
Operating Margin | 11.96% | 16.28% | 11.77% | 15.43% | 17.92% | 16.46% |
Earnings before Tax (EBT) 1 | 108.9 | 204.8 | 148.4 | 288.8 | 541.1 | 559.7 |
Net income 1 | 75.81 | 150.2 | 109.6 | 210.9 | 417 | 390.1 |
Net margin | 5.18% | 8.74% | 5.17% | 8.69% | 12.36% | 10.8% |
EPS 2 | 2.850 | 5.640 | 4.110 | 2.640 | 5.210 | 4.880 |
Free Cash Flow | - | -150.9 | -352.6 | -44.98 | 528.3 | 559.5 |
FCF margin | - | -8.78% | -16.65% | -1.85% | 15.66% | 15.5% |
FCF Conversion (EBITDA) | - | - | - | - | 72.96% | 78.19% |
FCF Conversion (Net income) | - | - | - | - | 126.7% | 143.43% |
Dividend per Share | - | - | 1.500 | 6.000 | - | 4.000 |
Announcement Date | 22/05/19 | 22/05/19 | 04/08/20 | 14/10/21 | 27/06/22 | 16/10/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 770 | 861 | 1,168 | 1,209 | 879 | 660 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.011 x | 2.377 x | 3.321 x | 2.461 x | 1.214 x | 0.9225 x |
Free Cash Flow | - | -151 | -353 | -45 | 528 | 559 |
ROE (net income / shareholders' equity) | - | 13.9% | 9.03% | 16.2% | 28.6% | 24.1% |
ROA (Net income/ Total Assets) | - | 7.21% | 5.53% | 7.48% | 11.8% | 11.4% |
Assets 1 | - | 2,083 | 1,982 | 2,819 | 3,534 | 3,413 |
Book Value Per Share 2 | 33.90 | 42.30 | 48.40 | 52.30 | 19.80 | 20.70 |
Cash Flow per Share 2 | 0.1400 | 0.7100 | 0.1900 | 2.660 | 1.030 | 0.8300 |
Capex 1 | 129 | 253 | 470 | 60.5 | 73 | 98.3 |
Capex / Sales | 8.84% | 14.71% | 22.21% | 2.49% | 2.16% | 2.72% |
Announcement Date | 22/05/19 | 22/05/19 | 04/08/20 | 14/10/21 | 27/06/22 | 16/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 152M | |
-22.44% | 15.75B | |
+3.60% | 12.47B | |
+3.98% | 11.73B | |
+3.69% | 10.24B | |
+26.63% | 8.51B | |
-7.49% | 7.38B | |
+7.08% | 6.78B | |
+4.83% | 6.25B | |
-3.14% | 4.33B |
- Stock Market
- Equities
- GPTHEALTH Stock
- Financials GPT Healthcare Limited